DexCom, Inc. filed its quarterly report on Form 10-Q with the SEC on October 29, 2026, covering the fiscal quarter ended September 30, 2026.

Key Highlights

  • Shares outstanding: As of October 22, 2026, there were 372,950,922 shares of common stock outstanding, according to the filing.
  • Total assets: The company reported total assets of $6,238.8 million as of September 30, 2026, compared with $6,339.9 million as of December 31, 2025.
  • Cash and cash equivalents: The balance sheet showed $961.4 million in cash and cash equivalents as of September 30, 2026, up from $917.7 million at year-end 2025.
  • Inventory: Inventory rose to $770.7 million as of September 30, 2026, from $629.1 million as of December 31, 2025.
  • Long-term senior convertible notes: The filing reported $1,243.7 million in long-term senior convertible notes as of September 30, 2026.
  • Accounts payable and accrued liabilities: Current accounts payable and accrued liabilities were $2,065.6 million, up from $1,944.0 million at December 31, 2025.

DexCom Balance Sheet Highlights for the September 30, 2026 Quarter

DexCom, Inc. (NASDAQ:DXCM), headquartered in San Diego, California, submitted its Form 10-Q for the quarterly period ended September 30, 2026. The filing is classified as a large accelerated filer and was submitted electronically to the SEC. The registrant's common stock, with a par value of $0.001 per share, is listed on the Nasdaq Global Select Market under the symbol DXCM.

According to the condensed consolidated balance sheets included in the filing, total current assets declined to $3,916.0 million from $4,033.3 million at December 31, 2025. Within current assets, short-term marketable securities fell to $856.5 million from $1,081.0 million, while accounts receivable, net, decreased slightly to $1,186.2 million from $1,216.1 million. Property and equipment, net, stood at $1,543.1 million as of September 30, 2026, compared with $1,559.9 million at year-end 2025. Intangibles, net, increased to $89.4 million from $70.8 million over the same period.

On the liabilities side, total current liabilities rose to $2,252.6 million from $2,142.5 million at December 31, 2025. Long-term operating lease liabilities were $77.5 million, and other long-term liabilities were $129.6 million. The filing notes that forward-looking statements within the report are subject to the company's cautionary language and are not guarantees of future performance, as described in the filing's risk factors section.

What Was Disclosed

DexCom filed its Form 10-Q for the quarter ended September 30, 2026, presenting unaudited condensed consolidated balance sheet data. Key balance sheet items include total assets of $6,238.8 million, cash of $961.4 million, and long-term convertible notes of $1,243.7 million.